Encompass Health Corp (EHC) valuation history

$124.09

Latest weekly close · Market cap $12.4B

Share EHC EV/EBITDA history
Within its usual range

As of

EHC's EV/EBITDA of 9.9x is lower than 59% of its weekly readings since July 2022.

Weekly EV/EBITDA since July 2022

EV/EBITDA each weekMiddle half of its readingsMedian 10.3×
EV/EBITDA weekly history6×8×10×12×14×9.9×2023202420252026
Median
10.3×
Low to high
7.6×–11.8×
Versus median
-3%
History starts
July 2022

EV/EBITDA

41stpercentile

of its weekly readings since July 2022

Within its usual range

Growth, last 12 months vs the year before

Revenue
+9%slowing
EPS
+20%

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends.

PriceRevenue, last 12 monthsEPS, last 12 months100 = first reading
01002003002023202420252026

EV/EBITDA at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

EHC EV/EBITDA at each year-end
Year-endEV/EBITDA5-year percentile
9.9×25
10.1×42
9.7×54
8.0×73

Loading peers and related research…

About this history

What is EHC's current EV/EBITDA?
EHC's EV/EBITDA of 9.9x is lower than 59% of its weekly readings since July 2022.
What is EHC's five-year median EV/EBITDA?
10.3x. Half of EHC's weekly readings since July 2022 were higher and half were lower. This page has 225 weekly readings, from Jul 4, 2022 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?
No. The rank compares EHC only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

Source: SEC company filings and weekly market prices. Multiples use the last twelve months of financial results. Updated .

How the valuation data is built